Janet B. McGill
Washington University in St. Louis
212 Papers
924 Citations
Janet B. McGill is an academic researcher from Washington University in St. Louis. The author has contributed to research in topics: Diabetes mellitus & Medicine. The author has an hindex of 61, co-authored 182 publications.
Chat about Author
Papers
Multicenter, Randomized Trial of a Bionic Pancreas in Type 1 Diabetes.
Steven Russell,Roy W. Beck,Edward R. Damiano,Firas H. El-Khatib,Katrina J. Ruedy,Courtney A. Balliro,Zoey Li,Peter Calhoun,R. Paul Wadwa,Bruce A. Buckingham,Keren Zhou,Mark J. Daniels,Philip Raskin,Perrin C. White,Jane Lynch,Jeremy Pettus,Irl B. Hirsch,Robin Goland,John B. Buse,Davida F. Kruger,Nelly Mauras,Andrew J. Muir,Janet B. McGill,Fran R. Cogen,Jill Weissberg-Benchell,Jordan Sherwood,Luz E. Castellanos,Mallory A. Hillard,Marwa Tuffaha,Melissa S. Putman,Mollie Y Sands,Gregory P. Forlenza,Robert H. Slover,Laurel H. Messer,Erin Cobry,Viral N. Shah,Sarit Polsky,Rayhan A. Lal,Laya Ekhlaspour,Michael E. Hughes,Marina Basina,Betul Hatipoglu,Leann Olansky,Amrit Bhangoo,Nikta Forghani,Himala Kashmiri,F. Sutton,Abha Choudhary,Jimmy Penn,Rabab Z. Jafri,Maria Rayas,Elia Escaname,Catherine Graham Jane Kerr,Ruby Favela-Prezas,Schafer Boeder,Subbulaxmi Trikudanathan,Kristen M. Williams,Natasha I. Leibel,M. Sue Kirkman,Katherine Bergamo,Klara R. Klein,Jean M. Dostou,Sriram Machineni,Laura A. Young,Jamie Diner,Arti Bhan,John K Jones,Matthew Benson,Keisha Bird,Kim Englert,Joseph Permuy,Kristina Cossen,Eric I. Felner,Maamoun Salam,Julie Silverstein,S.J. Adamson,Andrea Cedeno,Seema Meighan,Andrew Dauber +78 more
TL;DR: In this paper , a 13-week randomized trial involving adults and children with type 1 diabetes, using a bionic pancreas was associated with a greater reduction than standard care in the glycated hemoglobin level.
Similar risk of malignancy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: findings from a 5 year randomised, open-label study.
Julio Rosenstock,Vivian Fonseca,Janet B. McGill,Matthew C. Riddle,J.-P. Hallé,Irene Hramiak,P. Johnston,M. Davis +7 more
TL;DR: Although the study was not designed to investigate the frequency of tumour development, the long duration of the trial enables a comparative assessment of the occurrence of benign or malignant tumours with insulin glargine and NPH insulin during more than 4 years of exposure, captured as adverse events in the course of routine safety monitoring.
Fat-free foods supplemented with soy stanol-lecithin powder reduce cholesterolabsorption and LDL cholesterol
Curtis A. Spilburg,Anne C. Goldberg,Janet B. McGill,William F. Stenson,Susan B. Racette,Joyce Bateman,Timothy B McPherson,Richard E. Ostlund +7 more
TL;DR: It is shown that fat-free, lecithin-formulated soy stanols lower cholesterol absorption and serum LDL cholesterol when consumed inFat-free foods and inhibition of cholesterol absorption was determined from the difference in plasma deuterated cholesterol enrichment after a test meal containing stanol-leCithin and one with lecitin vehicle only.
Role of Orlistat in the Treatment of Obese Patients With Type 2 Diabetes: A 1-year randomized double-blind study
Priscilla Hollander,Steven C. Elbein,Irl B. Hirsch,David E. Kelley,Janet B. McGill,Terry Taylor,Stuart R Weiss,Samuel E Crockett,Roy Kaplan,John Comstock,Charles P. Lucas,Peter A Lodewick,William Canovatchel,Jain Chung,Jonathan Hauptman +14 more
TL;DR: Orlistat is an effective treatment modality in obese patients with type 2 diabetes with respect to clinically meaningful weight loss and maintenance of weight loss, improved glycemic control, and improved lipid profile.